"10.1371_journal.pone.0055285","plos one","2013-02-01T00:00:00Z","Benjamin Maasoumy; Kerstin Port; Antoaneta Angelova Markova; Beatriz Calle Serrano; Magdalena Rogalska-Taranta; Lisa Sollik; Carola Mix; Janina Kirschner; Michael P Manns; Heiner Wedemeyer; Markus Cornberg","Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany","Assesment of data: BM KP AM BCS MRT LS CM JK. Conceived and designed the experiments: BM MPM HW MC. Analyzed the data: BM HW MC. Wrote the paper: BM MPM HW MC.","The authors have read the journals policy and declare the following conflicts concerning Peg-Interferon alpha-2a (Roche), Peg-Interferon alpha-2b (Merck), Ribavirin (Roche, Merck), Boceprevir (Merck), Telaprevir (Janssen-Cilag): BM received travel grants from Merck and Janssen-Cilag, KP received lecture fees from Roche and Janssen-Cilag, AM declares no conflict, BCS received lecture fees from Merck, MRT declares no conflict, LS declares no conflict, JK declares no conflict, CM declares no conflict, MPM received grants, lectural fees and/or consult fees from Roche, Merck and Janssen-Cilag, HW received grants, lectural fees and/or consult fees from Roche, Merck and Janssen-Cilag. HW is also Academic Editor of PLOS ONE. MC received grants, lectural fees and/or consult fees from Roche, Merck and Janssen-Cilag. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Benjamin Maasoumy","BM",11,TRUE,4,NA,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
